Eliminate Viruses & Other Pathogens with Ease Kumar Jeetendra | April 20, 2020 AMSBIO offer a trio of sterilization systems suitable for a range of applications from sterilizing small laboratory instruments to sterilizing large research facilities. These compact sterilizers use a mixture of ozone and UV to kill pathogenic organisms, including viruses, bacteria, and fungi. Ozone scrubbing technology enables the devices to convert ozone gas back to oxygen, …
Investigating the Role of Heparins in Combating Covid-19 Infection Kumar Jeetendra | June 8, 2020 AMSBIO reports on the pioneering work by researchers at the University of Sheffield, UK** to measure the interaction between the SARS-CoV-2 Spike S1 protein receptor binding domain (SARS-CoV-2 S1 RBD) and heparin. This has resulted in a new assay which could be a useful first screen for novel inhibitors of coronavirus infection. Evidence is mounting …
New Range of SARS-CoV-2 Spike Protein Products Kumar Jeetendra | June 17, 2020 AMSBIO has launched a range of ready-to-use SARS-CoV-2 Spike protein coupled magnetic beads that combine convenience, minimum non-specific binding and developed operational protocols saving you time and hassle. Developed for immunocapture, cell stimulating, biopanning and flow cytometry applications these new products use biotinylated SARS-CoV-2 Spike protein pre-coupled to streptavidin conjugated magnetic beads, which can capture …
Biotinylated Heparan Sulfate Antibodies Kumar Jeetendra | April 29, 2021 AMSBIO has launched two new biotinylated formats of the 10E4 Heparan Sulfate antibody (high and low biotin) along with a starter pack to allow scientists to test both formats at a reduced cost. Heparan Sulfate (HS) is a highly sulfated linear polysaccharide that is attached to a core protein to form HS Proteoglycans on the …
Adeno-Associated Virus (AAV) Reference Materials Kumar Jeetendra | May 12, 2021 AMSBIO has announced a new range of AAV reference materials of full capsids and empty capsids of 6 different serotypes. Critical to enable meaningful comparisons between research studies and clinical trials, these well-characterized reference standards are extensively quality analyzed with molecular based assays and transmission electron microscope. Gene therapy researchers have long expressed the importance …
Cryopreservation Media helps in Development of a Cell Therapy for Parkinson’s Disease Kumar Jeetendra | June 5, 2021 AMSBIO reports upon a publication** that cites how its STEM-CELLBANKER® animal-free cryopreservation media has played a role in the development of a cell therapy for Parkinson’s Disease that will soon be going into clinical trials. Parkinson’s disease is one of the most common neurodegenerative diseases worldwide. Its main features include motor symptoms such as bradykinesia, …
GMP-compliant products for pre-clinical and ATMP research Kumar Jeetendra | October 7, 2022 Life science and healthcare specialists – AMSBIO reports upon its extensive range of high quality GMP-compliant products and services for pre-clinical and advanced therapy medical products (ATMP) research. Good Manufacturing Practice (GMP) is an internationally recognized system which ensures that products are consistently manufactured to a high-quality and provides key guidelines for the manufacture of …
Advancing Clinical Trials with iPSC-Derived Liver Organoids Kumar Jeetendra | August 9, 2023 AMSBIO has published a blog about Dr. Satoshi Okamoto’s groundbreaking research on the production of induced pluripotent stem cells (iPSC)-derived liver organoids, and their significant potential in clinical research trials. The primary objective of Dr. Okamoto’s research program at the Yokohama City University Graduate School’s Department of Regenerative Medicine was to achieve large-scale, stable production …
